Literature DB >> 4540955

Antibody production in mice. V. The suppressive effect of anti-carrier antibodies on cellular cooperation in the induction of secondary anti-hapten antibody responses.

T Hamaoka, K Takatsu, M Kitagawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4540955      PMCID: PMC1422970     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  23 in total

1.  The carrier effect in the secondary response to hapten-protein conjugates. V. Use of antilymphocyte serum to deplete animals of helper cells.

Authors:  N A Mitchison
Journal:  Eur J Immunol       Date:  1971-04       Impact factor: 5.532

2.  Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen.

Authors:  A Basten; J F Miller; N L Warner; J Pye
Journal:  Nat New Biol       Date:  1971-05-26

3.  Cell cooperation in antibody induction. The susceptibility of helper cells to specific lethal radioactive antigen.

Authors:  G E Roelants; B A Askonas
Journal:  Eur J Immunol       Date:  1971-06       Impact factor: 5.532

4.  Antibody production in mice. 3. The suppressive effect of antibody on the initiation of secondary immune response.

Authors:  T Hamaoka; K Takatsu; H Masaki; Y Matsuoka; M Kitagawa
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

5.  Immunogenicity of glucagon: determinants responsible for antibody binding and lymphocyte stimulation.

Authors:  G Senyk; D Nitecki; J W Goodman
Journal:  Science       Date:  1971-01-29       Impact factor: 47.728

Review 6.  Antigen binding cells in tolerance and immunity.

Authors:  G L Ada
Journal:  Transplant Rev       Date:  1970

7.  Antibody production in mice. II. The mechanism of antigenic stimulation in the secondary immune response.

Authors:  T Hamaoka; M Kitagawa
Journal:  Immunology       Date:  1971-02       Impact factor: 7.397

8.  The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response.

Authors:  M Feldmann; A Easten
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

9.  Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses.

Authors:  W E Paul; D H Katz; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

10.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

View more
  5 in total

1.  Inhibitory effect of carrier and hapten preimmunization on delayed hypersensitivity to the carrier.

Authors:  P J Neveu
Journal:  Immunology       Date:  1976-08       Impact factor: 7.397

2.  Antibody production in mice. VI. Effect of anti-carrier antibody on cellular co-operation in the primary anti-hapten antibody response.

Authors:  K Takatsu; T Hamaoka; M Kitagawa
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

3.  Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: analysis in a viral model.

Authors:  S C Gupta; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

Review 4.  Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.

Authors:  Stephen Brimijoin; Xiaoyun Shen; Frank Orson; Thomas Kosten
Journal:  Expert Rev Vaccines       Date:  2013-03       Impact factor: 5.217

5.  Hapten-specific IgE antibody responses in mice. II. Cooperative interactions between adoptively transferred T and B lymphocytes in the development of IgE response.

Authors:  T Hamaoka; D H Katz; B Benacerraf
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.